4D pharma plc Deferred Tax Liabilities, Intangible Assets
4D pharma plc had Deferred Tax Liabilities, Intangible Assets of $1.52 million as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2022-03-31
- 2021-12-31: Deferred Tax Liabilities, Intangible Assets $1.52M.
- 2020-12-31: Deferred Tax Liabilities, Intangible Assets $1.17M.
- 2019-12-31: Deferred Tax Liabilities, Intangible Assets $1.01M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2021-12-31 | $1.52M 20-F · filed 2022-03-31 |
| 2020-12-31 | $1.17M 20-F · filed 2022-03-31 |
| 2019-12-31 | $1.01M 20-F/A · filed 2021-04-30 |